Comparison of Three Assays to Quantify Infliximab, Adalimumab, and Etanercept Serum Concentrations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Three Assays to Quantify Infliximab, Adalimumab, and Etanercept Serum Concentrations

Published:2016-08 Issue:4 Volume:38 Page:432-438
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

van Bezooijen Ji S.,Koch Birgit C. P.,van Doorn Martijn B. A.,Prens Errol P.,van Gelder Teun,Schreurs Marco W. J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference13 articles.

1. Clinical relevance of immunogenicity of biologics in psoriasis: implications for treatment strategies;Carrascosa;J Eur Acad Dermatol Venereol.,2014

2. Monitoring antigen-specific biologics: current knowledge and future prospects;Zandvliet;Ther Drug Monit.,2013

3. Toward a personalized medicine approach to the management of inflammatory bowel disease;Mosli;Am J Gastroenterol.,2014

4. The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept;Jamnitski;Ann Rheum Dis.,2011

5. Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation;van Schouwenburg;Ann Rheum Dis.,2013

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Performance of Two Automated Anti-drug Antibodies Assays for Infliximab and Adalimumab Without Acid Dissociation;The AAPS Journal;2024-07-24

2. Population Pharmacokinetics of Adalimumab in Juvenile Idiopathic Arthritis Patients: A Retrospective Cohort Study Using Clinical Care Data;Pediatric Drugs;2024-04-17

3. Comparison of Two Clinical Laboratory Assays for Measuring Serum Adalimumab and Antibodies to Adalimumab;The Journal of Applied Laboratory Medicine;2023-09-02

4. Cost-effectiveness of therapeutic drug monitoring (TDM) of biologic treatment in rheumatic diseases: a narrative review;Biotechnology & Biotechnological Equipment;2023-08-27

5. Validation Study of Novel Point-of-Care Tests for Infliximab, Adalimumab and C-Reactive Protein in Capillary Blood and Calprotectin in Faeces in an Ambulatory Inflammatory Bowel Disease Care Setting;Diagnostics;2023-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3